Keyword: OxyContin

With its oral semaglutide up for FDA review, Novo Nordisk is hunting for opportunities to boost its supply chain, and it found one in North Carolina.

Prosecutors are looking for ways to hold Purdue's founding family accountable for their role in the opioid epidemic. Arizona’s AG may have found one.

Oklahoma prosecutors have already bagged two settlements in its crusade against opioid drugmakers. Now it’s taking a swing at a third in court.

The WHO’s role in part is to provide prescribing guidance without an eye on profits. What happens when that guidance is tainted by private money?

Purdue took a big hit when it settled with Oklahoma over claims it misleadingly advertised its powerful opioid, OxyContin. Now more states want in.

The Sackler family directed Purdue sales tactics for OxyContin and should be held responsible, Massachusetts' AG says.

Two Democratic senators are looking into whether Rudy Giuliani secured leniency for Purdue Pharma through conflicts of interest.

Embattled OxyContin maker Purdue Pharma distances itself even further from the powerful painkillers that made it infamous.

A lawsuit from Massachusetts is the first to target Purdue executives and directors, according to the state's attorney general.

Even as the U.S. opioid crisis deepened and lawsuits flourished, Purdue Pharma continued to market Oxycontin to doctors. But no longer.